Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic.
About Roche Diagnostics
Learn how the SARS-CoV-2 Rapid Antibody Test works
Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2
Immunoassay for the quantitative determination of antibodies to the SARS-CoV-2 spike protein
Immunoassay for the qualitative detection of antibodies (incl. IgG) against SARS-CoV-2
High-throughput, reliable and accurate differential diagnosis of COVID-19 and influenza
Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.
The world’s leading supplier of in vitro diagnostic solutions, instrument systems, tests, and services.
Enabling healthcare professionals to effectively diagnose and manage disease while personalizing patient treatment options
Providing staining and instrument systems that automate and optimize the tissue diagnostic process for faster, more standardized answers
Integrating diagnostics through physical and virtual workflow automation, software solutions, and business analytics